Werewolf Therapeutics, Inc. · NASDAQ:HOWL

Luke Evnin sold 44,679 Werewolf Therapeutics, Inc. shares (Form 4)

Traded May 13, 2026 · Filed May 13, 2026

On May 13, 2026, Luke Evnin (Director) sold 44,679 Werewolf Therapeutics, Inc. shares at US$0.54 for US$24,127 under a trading plan, leaving 1,126,496 shares. Filed May 13, 2026 (Form 4).

Sold
44,679 shares
Price
US$0.54
Value
US$24,127
Holding after
1,126,496 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 13, 2026Common StockSale44,679US$0.541,126,496Indirect

Source

View original at SEC

Related